Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM)

Q: What does CUSIP 00773U108 represent in this 13F holders report?

CUSIP 00773U108 is the security identifier for ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share in Q2 2020?

140 institutional investors reported ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share for Q2 2020. Use the holders table for investor-level position and value details.

CUSIP: 00773U108

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 22,163,711
Total 13F shares: 80,871,445
Share change: +971,383
Total reported value: $1,688,585,259
Put/Call ratio: 32%
Price per share: $20.88
Number of holders: 140
Value change: +$34,736,142
Number of buys: 89
Number of sells: 49

Quarterly Holders Quick Answers

What is CUSIP 00773U108?
CUSIP 00773U108 identifies ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 00773U108:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RA CAPITAL MANAGEMENT, L.P.	13F	Company	33%	7,272,714	$71,054,000	—	31 Mar 2020	13F
Avoro Capital Advisors LLC	13F	Company	32%	7,150,000	$69,856,000	—	31 Mar 2020	13F
Versant Venture Management, LLC	13F	Company	32%	7,068,233	$69,056,636	—	31 Mar 2020	13F
RTW INVESTMENTS, LP	13F	Company	30%	6,631,627	$64,791,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	23%	5,044,527	$49,285,000	—	31 Mar 2020	13F
Sonic Fund II, L.P.	13F	Company	19%	4,112,355	$40,178,000	—	31 Mar 2020	13F
ORBIMED ADVISORS LLC	13F	Company	16%	3,450,644	$33,713,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	15%	3,342,089	$32,652,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	14%	3,178,255	$31,051,000	—	31 Mar 2020	13F
UBS Group AG	13F	Company	11%	2,473,928	$24,170,000	—	31 Mar 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	11%	2,453,366	$23,969,000	—	31 Mar 2020	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	9.4%	2,075,000	$20,273,000	—	31 Mar 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	8.5%	1,878,245	$18,354,000	—	31 Mar 2020	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	8.1%	1,800,000	$17,586,000	—	31 Mar 2020	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	7.7%	1,704,500	$16,653,000	—	31 Mar 2020	13F
Ghost Tree Capital, LLC	13F	Company	5.9%	1,305,500	$12,755,000	—	31 Mar 2020	13F
FRAZIER MANAGEMENT LLC	13F	Company	5.8%	1,278,328	$12,489,000	—	31 Mar 2020	13F
CITADEL ADVISORS LLC	13F	Company	5.2%	1,143,044	$11,168,000	—	31 Mar 2020	13F
Casdin Capital, LLC	13F	Company	5.1%	1,125,000	$10,991,000	—	31 Mar 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	4.9%	1,084,148	$10,592,000	—	31 Mar 2020	13F
VR Adviser, LLC	13F	Company	4.5%	994,381	$9,715,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	4.1%	909,469	$8,885,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	4.1%	906,878	$8,860,000	—	31 Mar 2020	13F
WS MANAGEMENT LLLP	13F	Company	3.7%	816,945	$7,982,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	3.6%	801,199	$7,827,000	—	31 Mar 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	3.6%	792,822	$7,746,000	—	31 Mar 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	3.4%	754,513	$7,371,592	—	31 Mar 2020	13F
Artal Group S.A.	13F	Company	2.7%	600,000	$5,862,000	—	31 Mar 2020	13F
Rhenman & Partners Asset Management AB	13F	Company	2.5%	550,000	$5,374,000	—	31 Mar 2020	13F
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA)	13F	Company	2.2%	480,000	$4,690,000	—	31 Mar 2020	13F
Invesco Ltd.	13F	Company	1.8%	394,474	$3,854,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	1.7%	385,156	$3,763,000	—	31 Mar 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.7%	378,014	$3,693,000	—	31 Mar 2020	13F
Soleus Capital Management, L.P.	13F	Company	1.4%	313,900	$3,067,000	—	31 Mar 2020	13F
Allianz Asset Management GmbH	13F	Company	1.4%	302,206	$2,952,000	—	31 Mar 2020	13F
BARCLAYS PLC	13F	Company	1.2%	268,681	$2,626,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	1.2%	258,698	$2,527,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	1.1%	247,280	$2,416,000	—	31 Mar 2020	13F
First Light Asset Management, LLC	13F	Company	1.1%	242,300	$2,367,000	—	31 Mar 2020	13F
S.c.a. Candriam	13F	Individual	0.9%	200,000	$2,252,000	—	31 Mar 2020	13F
COWEN AND COMPANY, LLC	13F	Company	0.99%	218,624	$2,136,000	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.96%	213,563	$2,087,000	—	31 Mar 2020	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.8%	177,428	$1,733,000	—	31 Mar 2020	13F
FMR LLC	13F	Company	0.79%	175,008	$1,710,000	—	31 Mar 2020	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.76%	168,191	$1,643,226	—	31 Mar 2020	13F
Burrage Capital Management LLC	13F	Company	0.7%	156,012	$1,559,000	—	31 Mar 2020	13F
Global IMC LLC	13F	Company	0.62%	137,626	$1,345,000	—	31 Mar 2020	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.6%	132,297	$1,293,000	—	31 Mar 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.57%	126,456	$1,235,000	—	31 Mar 2020	13F
Swiss National Bank	13F	Company	0.52%	115,000	$1,124,000	—	31 Mar 2020	13F

Institutional Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q2 2020

As of 30 Jun 2020, Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) was held by 140 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 80,871,445 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, Versant Venture Management, LLC, RTW INVESTMENTS, LP, BlackRock Inc., Sonic Fund II, L.P., VANGUARD GROUP INC, STATE STREET CORP, ORBIMED ADVISORS LLC, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 140 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

125

Q2 2020 holders

140

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.